Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 4;171(12):e173438.
doi: 10.1001/jamapediatrics.2017.3438. Epub 2017 Dec 4.

Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management

Linyan Meng  1   2 , Mohan Pammi  3 , Anirudh Saronwala  1 , Pilar Magoulas  1   4 , Andrew Ray Ghazi  1 , Francesco Vetrini  2 , Jing Zhang  2 , Weimin He  2 , Avinash V Dharmadhikari  2 , Chunjing Qu  2 , Patricia Ward  1   2 , Alicia Braxton  1   2 , Swetha Narayanan  1   2 , Xiaoyan Ge  1 , Mari J Tokita  1 , Teresa Santiago-Sim  1 , Hongzheng Dai  1 , Theodore Chiang  5 , Hadley Smith  1 , Mahshid S Azamian  1 , Laurie Robak  1 , Bret L Bostwick  1   4 , Christian P Schaaf  1   4 , Lorraine Potocki  1   4 , Fernando Scaglia  1   4 , Carlos A Bacino  1   4 , Neil A Hanchard  1   4 , Michael F Wangler  1   4 , Daryl Scott  1   4   6 , Chester Brown  7 , Jianhong Hu  5 , John W Belmont  1 , Lindsay C Burrage  1   4 , Brett H Graham  1 , Vernon Reid Sutton  1   4 , William J Craigen  1   4 , Sharon E Plon  1   4   8 , James R Lupski  1   4   5   9 , Arthur L Beaudet  1 , Richard A Gibbs  5 , Donna M Muzny  5 , Marcus J Miller  1   2 , Xia Wang  1   2 , Magalie S Leduc  1   2 , Rui Xiao  1   2 , Pengfei Liu  1   2 , Chad Shaw  1 , Magdalena Walkiewicz  1   2 , Weimin Bi  1   2 , Fan Xia  1   2 , Brendan Lee  1 , Christine M Eng  1   2 , Yaping Yang  1   2 , Seema R Lalani  1   2   4
Affiliations

Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management

Linyan Meng et al. JAMA Pediatr. .

Abstract

Importance: While congenital malformations and genetic diseases are a leading cause of early infant death, to our knowledge, the contribution of single-gene disorders in this group is undetermined.

Objective: To determine the diagnostic yield and use of clinical exome sequencing in critically ill infants.

Design, setting, and participants: Clinical exome sequencing was performed for 278 unrelated infants within the first 100 days of life who were admitted to Texas Children's Hospital in Houston, Texas, during a 5-year period between December 2011 and January 2017. Exome sequencing types included proband exome, trio exome, and critical trio exome, a rapid genomic assay for seriously ill infants.

Main outcomes and measures: Indications for testing, diagnostic yield of clinical exome sequencing, turnaround time, molecular findings, patient age at diagnosis, and effect on medical management among a group of critically ill infants who were suspected to have genetic disorders.

Results: The mean (SEM) age for infants participating in the study was 28.5 (1.7) days; of these, the mean (SEM) age was 29.0 (2.2) days for infants undergoing proband exome sequencing, 31.5 (3.9) days for trio exome, and 22.7 (3.9) days for critical trio exome. Clinical indications for exome sequencing included a range of medical concerns. Overall, a molecular diagnosis was achieved in 102 infants (36.7%) by clinical exome sequencing, with relatively low yield for cardiovascular abnormalities. The diagnosis affected medical management for 53 infants (52.0%) and had a substantial effect on informed redirection of care, initiation of new subspecialist care, medication/dietary modifications, and furthering life-saving procedures in select patients. Critical trio exome sequencing revealed a molecular diagnosis in 32 of 63 infants (50.8%) at a mean (SEM) of 33.1 (5.6) days of life with a mean (SEM) turnaround time of 13.0 (0.4) days. Clinical care was altered by the diagnosis in 23 of 32 patients (71.9%). The diagnostic yield, patient age at diagnosis, and medical effect in the group that underwent critical trio exome sequencing were significantly different compared with the group who underwent regular exome testing. For deceased infants (n = 81), genetic disorders were molecularly diagnosed in 39 (48.1%) by exome sequencing, with implications for recurrence risk counseling.

Conclusions and relevance: Exome sequencing is a powerful tool for the diagnostic evaluation of critically ill infants with suspected monogenic disorders in the neonatal and pediatric intensive care units and its use has a notable effect on clinical decision making.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures

The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the clinical exome sequencing offered at the Baylor Genetics and the authors who are faculty members are indicated in the affiliation section.

Yang is a member of the Scientific Advisory Board (SAB) of Veritas Genetics China.

No other disclosures were reported.

Comment in

  • A Time to Sequence.
    Baxter SK, King MC. Baxter SK, et al. JAMA Pediatr. 2017 Dec 4;171(12):e173435. doi: 10.1001/jamapediatrics.2017.3435. Epub 2017 Dec 4. JAMA Pediatr. 2017. PMID: 28973099 No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Synnes AR, Berry M, Jones H, Pendray M, Stewart S, Lee SK. Infants with congenital anomalies admitted to neonatal intensive care units. Am J Perinatol. 2004;21(4):199–207. - PubMed
    1. Widmann R, Caduff R, Giudici L, et al. Value of postmortem studies in deceased neonatal and pediatric intensive care unit patients. Virchows Arch. 2017;470(2):217–223. - PubMed
    1. Hoyert DL, Freedman MA, Strobino DM, Guyer B. Annual summary of vital statistics: 2000. Pediatrics. 2001;108(6):1241–1255. - PubMed
    1. Stevenson DA, Carey JC. Contribution of malformations and genetic disorders to mortality in a children’s hospital. Am J Med Genet A. 2004;126A(4):393–397. - PubMed
    1. Hudome SM, Kirby RS, Senner JW, Cunniff C. Contribution of genetic disorders to neonatal mortality in a regional intensive care setting. Am J Perinatol. 1994;11(2):100–103. - PubMed

Publication types

-